Constitutively-active androgen receptor variants function independently of the HSP90 chaperone but do not confer resistance to HSP90 inhibitors

Constitutively-active androgen receptor variants function independently of the HSP90 chaperone but do not confer resistance to HSP90 inhibitors

The development of lethal, castration resistant prostate cancer is associated with adaptive changes to the androgen receptor (AR), including the emergence of mutant receptors and truncated, constitutively active AR variants. AR relies on the molecular chaperone HSP90 for its function in both normal...

Full description

Bibliographic Details
Main Authors: Gillis, Joanna L., Selth, Luke A., Centenera, Margaret M., Townley, Scott L., Sun, Shihua, Plymate, Stephen R., Tilley, Wayne D., Butler, Lisa M.
Format: Online
Language:English
Published: Impact Journals LLC 2013
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3742830/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3742830/

Similar Items